Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Agnieszka Wozniak"'
Autor:
Annelies Verbiest, Patrick Schöffski, Jessica Zucman-Rossi, Gabrielle Couchy, Stefano Caruso, Agnieszka Wozniak, Laurence Albiges, Wolf-Hervé Fridman, Nathalie Rioux-Leclercq, Reza-Thierry Elaidi, Maarten Albersen, Catherine Sautès-Fridman, Benoit Beuselinck, Stéphane Oudard, Inne Renders, Virginie Verkarre, Sylvie Job, Annouschka Laenen, Yann Vano, Evelyne Lerut
Publikováno v:
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, Elsevier, 2019, 17 (5), pp.e981-e994. ⟨10.1016/j.clgc.2019.05.009⟩
Clinical Genitourinary Cancer, 2019, 17 (5), pp.e981-e994. ⟨10.1016/j.clgc.2019.05.009⟩
Clinical Genitourinary Cancer, Elsevier, 2019, 17 (5), pp.e981-e994. ⟨10.1016/j.clgc.2019.05.009⟩
Clinical Genitourinary Cancer, 2019, 17 (5), pp.e981-e994. ⟨10.1016/j.clgc.2019.05.009⟩
INTRODUCTION: Recent trials have suggested predictive biomarkers in advanced clear-cell renal cell carcinoma (accRCC): International Metastatic RCC Database Consortium (IMDC) good risk or angiogenic gene signature for sunitinib and IMDC intermediate/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab6dac2d13ea1013fedbdc6b96d2acfc
https://hal.archives-ouvertes.fr/hal-02454456
https://hal.archives-ouvertes.fr/hal-02454456
Autor:
Axelle Nzokirantevye, Sandrine Marreaud, Hans Gelderblom, Sandra Collette, Patrick Schöffski, Silvia Stacchiotti, Agnieszka Wozniak, Piotr Rutkowski, Nicolas Isambert, Lars H. Lindner, Antoine Italiano, Sandra J. Strauss, Jozef Sufliarsky, Raf Sciot, Jean-Yves Blay, Thomas Van Cann, Maria Debiec-Rychter, Michael G Leahy
Publikováno v:
Lancet Respiratory medicine
Lancet Respiratory medicine, Elsevier, 2018, 6 (6), pp.431-441. ⟨10.1016/S2213-2600(18)30116-4⟩
Lancet Respiratory Medicine, 6(6), 431-441
Lancet Respiratory medicine, Elsevier, 2018, 6 (6), pp.431-441. ⟨10.1016/S2213-2600(18)30116-4⟩
Lancet Respiratory Medicine, 6(6), 431-441
Summary Background An inflammatory myofibroblastic tumour (IMFT) is a rare mesenchymal neoplasm characterised by anaplastic lymphoma kinase (ALK) gene rearrangements. We assessed the activity and safety of crizotinib, a tyrosine kinase inhibitor, tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67c1075a5e10c272f915c04bb3ed763
https://hal.archives-ouvertes.fr/hal-01958081
https://hal.archives-ouvertes.fr/hal-01958081